Greater Cannabis Company (GCAN) Share-based Compensation (2017 - 2025)
Greater Cannabis Company's (GCAN) quarterly Share-based Compensation came in at $1800.0 in Q1 2025, down 85.31% quarter-over-quarter from $12250.0 in Q3 2019.
Greater Cannabis Company (GCAN) Share-based Compensation (2017 - 2025) Analysis & Trends
Greater Cannabis Company's Share-based Compensation history runs 4 years deep, the most recent figure standing at $1800.0 for Q1 2025.
- On a quarterly basis, Share-based Compensation changed N/A year-over-year to $1800.0 in Q1 2025; TTM through Mar 2025 was $14050.0, a N/A change from a year earlier, with the FY2019 full-year figure at $88130.0, changed N/A from the prior year.
- Share-based Compensation eased to $1800.0 in Q1 2025 per GCAN's latest filing, from $12250.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $1800.0 in Q1 2025 and bottomed at $1800.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1,800.00 |
| Mar 31, 2025 | 1,800.00 |
| Sep 30, 2019 | 12,250.00 |
| Sep 30, 2019 | 12,250.00 |
| Mar 31, 2018 | 2,500.00 |
| Mar 31, 2018 | 2,500.00 |
| Dec 31, 2017 | 7,125.00 |
| Dec 31, 2017 | 7,125.00 |
| Sep 30, 2017 | 2,500.00 |
| Sep 30, 2017 | 2,500.00 |
| Jun 30, 2017 | 2,500.00 |
| Jun 30, 2017 | 2,500.00 |
| Mar 31, 2017 | 525,000.00 |
| Mar 31, 2017 | 525,000.00 |